top
Search terms
Results 1 - 1 of 1 - ordered by :
Epeuropace

During a mean follow-up of 50 months, 6.4% of patients had a combined endpoint [sudden death or appropriate implantable cardioverter-defibrillator (ICD) therapy]. The results of our multivariate ...

Europace, CLINICAL RESEARCH, Majid Haghjoo, Shabnam Mohammadzadeh, Mehdi Taherpour, Babak Faghfurian, Amir Farjam Fazelifar, Abolfath Alizadeh, Mohammad Asadian Rad, Mohammad Ali Sadr-Ameli

Date : 01/05/2009